Kit ELISA TRAIL sandwich (TNFSF10) (mouse): quantitative assay of Ms TRAIL in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms TRAIL.
Accession number
P50592
Dose range
2.46-600 pg/ml
Sensitivity of the dosage
2 pg/ml
Calibration range
2 pg/ml to 600 pg/ml
Dose
ELISA solid-phase sandwich
Brand
Invitrogen
Kit ELISA TRAIL sandwich (TNFSF10) (mouse): quantitative assay of Ms TRAIL in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms TRAIL.
Kit ELISA TRAIL sandwich (TNFSF10) (mouse): quantitative assay of Ms TRAIL in serum, plasma or cell culture medium. The test exclusively recognizes the natural and recombinant forms of Ms TRAIL.
Method principle: This ELISA solid phase sandwich test (immuno-enzymatic dose) measures the amount of target bound between a pair of matched antibodies. A specific target antibody is pre-adsorbed into the wells of the supplied microplate. Samples, standards or controls are added to these wells and bind to immobilized antibodies (capture antibodies). The sandwich is formed by adding the second antibody (detection antibody), then a substrate solution reacts with the enzyme-antibodies-target complex to produce a measurable signal. The intensity of this signal is directly proportional to the concentration of the target present in the original sample.
Rigorous validation: Each batch manufactured from this ELISA kit is checked for criteria such as sensitivity, specificity, accuracy and reproducibility from one batch to another (see the package leaflet for more information on validation).
TRAIL protein is a cytokine belonging to the tumour necrosis factor (TNF) family. TRAIL protein induces the apoptosis preferably in transformed and tumour cells, but does not appear to kill normal cells although it expresses itself at a significant level in most normal tissues. The TRAIL protein binds to several members of the TNF receptor superfamily, including TNFRSF10A / TRAILR1, TNFRSF10B / TRAILR2, TNFRSF10C /TRAILR3, TNFRSF10D / TRAILR4 and possibly also to TNFRSF11B / OPG. The activity of this protein can be modulated by binding to the lure receptors TNFRSF10C / TRAILR3, TNFRSF10D / TRAILR4 and TNFRSF11B / OPG which cannot induce d-apoptosis. The binding of the TRAIL protein to its receptors has been shown to trigger activation of the MAPK8/JNK protein, caspase 8 and caspase 3. Trail protein receptors include two receptor-based death domains, Death Receptor 4 (DR4) and DR5, as well as two lure receptors, DcR1 and DcR2, without any intracellular signaling death domain. TRAIL protein is a type II membrane protein and is expressed in a multitude of human tissues. Just like TNF and Fas ligand, TRAIL induces the apoptosis and active NF-kB in many tissues and cells.